Multiple lines of evidence of this study indicated that TPM3 mRNA was significantly increased in patients with metastatic cancer and could be delivered into cancer cells by microvesicles to promote the invasion of BC cells. Here, TPM3 is linked to metastatic malignant neoplasm.